[177Lu]Lu-PSMA-617
Drug timelines are a Plus or Pro feature.
1 regulatory and trial event tracked for [177Lu]Lu-PSMA-617, covering 2026-03-23 to 2026-03-23. Get the full timeline:
Most recent: Clinical Trial Update: A Study Evaluating [177Lu]Lu-PSMA-617 vs. a Change of Androgen Receptor-directed Therapy in Taxane Treatment Naive Chinese Male Patients With Progressive Metastatic Castrate Resistant Prostate Cancer [Phase 2]